# The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers

> **NCT01526304** · — · UNKNOWN · sponsor: **University of Zurich** · enrollment: 150 (estimated)

## Conditions studied

- Kidney Stones

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT01526304
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** —
- **Final completion:** 2014-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526304, "The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01526304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*